An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric

Conditions:   Esophagus Cancer, Stage III;   Esophageal Gastric Cardia Type Metaplasia;   Esophagus Cancer, Stage IV
Intervention:   Drug: Apatinib
Sponsor:   Tianjin Medical University Cancer Institute and Hospital
Recruiting - verified July 2017

http://ift.tt/2yjx0JP